349 related articles for article (PubMed ID: 12361720)
21. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
[TBL] [Abstract][Full Text] [Related]
22. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways.
Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M
Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755
[TBL] [Abstract][Full Text] [Related]
23. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
24. The establishment of the long terminal repeat of the mouse mammary tumor virus into CV-1 cells allows a functional analysis of steroid receptors.
Couette B; Le Ricousse S; Fortin D; Rafestin-Oblin ME; Richard-Foy H
Biochim Biophys Acta; 1994 Nov; 1219(3):607-12. PubMed ID: 7948018
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the glucocorticoid receptor represses transcription from hormone responsive and non-responsive promoters.
Hoeck W; Hofer P; Groner B
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):283-9. PubMed ID: 1314076
[TBL] [Abstract][Full Text] [Related]
26. Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1.
Chaudhry AZ; Vitullo AD; Gronostajski RM
J Biol Chem; 1999 Mar; 274(11):7072-81. PubMed ID: 10066764
[TBL] [Abstract][Full Text] [Related]
27. Antiprogestins mediate differential effects on glucocorticoid receptor remodeling of chromatin structure.
Fryer CJ; Nordeen SK; Archer TK
J Biol Chem; 1998 Jan; 273(2):1175-83. PubMed ID: 9422784
[TBL] [Abstract][Full Text] [Related]
28. Complex role of histone H1 in transactivation of MMTV promoter chromatin by progesterone receptor.
Vicent GP; Koop R; Beato M
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):15-23. PubMed ID: 12650697
[TBL] [Abstract][Full Text] [Related]
29. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
Deroo BJ; Rentsch C; Sampath S; Young J; DeFranco DB; Archer TK
Mol Cell Biol; 2002 Jun; 22(12):4113-23. PubMed ID: 12024025
[TBL] [Abstract][Full Text] [Related]
30. Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo.
Mymryk JS; Berard D; Hager GL; Archer TK
Mol Cell Biol; 1995 Jan; 15(1):26-34. PubMed ID: 7799933
[TBL] [Abstract][Full Text] [Related]
31. Interplay of steroid hormone receptors and transcription factors on the mouse mammary tumor virus promoter.
Truss M; Chalepakis G; Beato M
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):365-78. PubMed ID: 1327070
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
33. Single-cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription.
Voss TC; John S; Hager GL
Mol Endocrinol; 2006 Nov; 20(11):2641-55. PubMed ID: 16873444
[TBL] [Abstract][Full Text] [Related]
34. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter.
Préfontaine GG; Walther R; Giffin W; Lemieux ME; Pope L; Haché RJ
J Biol Chem; 1999 Sep; 274(38):26713-9. PubMed ID: 10480874
[TBL] [Abstract][Full Text] [Related]
35. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
36. The constitution of a progesterone response element.
Lieberman BA; Bona BJ; Edwards DP; Nordeen SK
Mol Endocrinol; 1993 Apr; 7(4):515-27. PubMed ID: 8388996
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of mouse mammary tumor virus-bacterial chloramphenicol acetyltransferase chimeric gene by human mineralocorticoid hormone-receptor complexes.
Govindan MV; Leclerc S; Roy R; Rathanaswami P; Xie BX
J Steroid Biochem Mol Biol; 1991 Jul; 39(1):91-103. PubMed ID: 1648951
[TBL] [Abstract][Full Text] [Related]
38. The hormone responsive region of mouse mammary tumor virus positions a nucleosome and precludes access of nuclear factor I to the promoter.
Candau R; Chávez S; Beato M
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):19-31. PubMed ID: 8645614
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator.
Heitzer MD; DeFranco DB
Mol Endocrinol; 2006 Jan; 20(1):56-64. PubMed ID: 16141357
[TBL] [Abstract][Full Text] [Related]
40. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
Boronat S; Richard-Foy H; Piña B
J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
